Ujala Yadav
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Ujala Yadav has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Ashish Kalkal
Institute of Biological Chemistry, Biophysics & Bioengineering School of Engineering & Physical Sciences Heriot‐Watt University Edinburgh UK
1 shared publication - Ashutosh Kumar
Department of Electrical Engineering, University of Notre Dame, Notre Dame, IN 46637, USA
1 shared publication - Damini Verma
Centre for Nanotechnology, Indian Institute of Technology Roorkee, Roorkee, Uttarakhand, 247667, India
1 shared publication - Kuldeep Mahato
University of California, San Diego
1 shared publication - Nivedita Priyadarshini
Department of Zoology, DAV PG College Siwan, Jai Prakash University, Chhapra 841226, Bihar, India
1 shared publication - Sumit K. Yadav
Hub Divyasmapark, Technology Innovation Hub, Indian Institute of Technology Roorkee, Roorkee, India
1 shared publication
Latest Publications
- Open Access
- 7 September 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (9) , 1744
Point-of-Care Devices for Viral Detection: COVID-19 Pandemic and Beyond
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of early, quick diagnostic tests for facilitating effective cure and management. The primary obstacles encountered were accurately distinguishing COVID-19 from other illnesses including the flu, common cold, etc. While the polymerase chain reaction technique is a robust technique for the determination of SARS-CoV-2 in patients of COVID-19, there arises a high demand for affordable, quick, user-friendly, and precise point-of-care (POC) diagnostic in therapeutic settings. The necessity for available tests with rapid outcomes spurred the advancement of POC tests that are characterized by speed, automation, and high precision and accuracy. Paper-based POC devices have gained increasing interest in recent years because of rapid, low-cost detection without requiring external instruments. At present, microfluidic paper-based analysis devices have garnered public attention and accelerated the development of such POCT for efficient multistep assays. In the current review, our focus will be on the fabrication of detection modules for SARS-CoV-2. Here, we have included a discussion on various strategies for the detection of viral moieties. The compilation of these strategies would offer comprehensive insight into the detection of the causative agent preparedness for future pandemics. We also provide a descriptive outline for paper-based diagnostic platforms, involving the determination mechanisms, as well as a commercial kit for COVID-19 as well as their outlook.
- 7 September 2023
- Published by MDPI AG in Micromachines
- Vol. 14 (9) , 1744
Open AccessPoint-of-Care Devices for Viral Detection: COVID-19 Pandemic and Beyond
The pandemic of COVID-19 and its widespread transmission have made us realize the importance of early, quick diagnostic tests for facilitating effective cure and management. The primary obstacles encountered were accurately distinguishing COVID-19 from other illnesses including the flu, common cold, etc. While the polymerase chain reaction technique is a robust technique for the determination of SARS-CoV-2 in patients of COVID-19, there arises a high demand for affordable, quick, user-friendly, and precise point-of-care (POC) diagnostic in therapeutic settings. The necessity for available tests with rapid outcomes spurred the advancement of POC tests that are characterized by speed, automation, and high precision and accuracy. Paper-based POC devices have gained increasing interest in recent years because of rapid, low-cost detection without requiring external instruments. At present, microfluidic paper-based analysis devices have garnered public attention and accelerated the development of such POCT for efficient multistep assays. In the current review, our focus will be on the fabrication of detection modules for SARS-CoV-2. Here, we have included a discussion on various strategies for the detection of viral moieties. The compilation of these strategies would offer comprehensive insight into the detection of the causative agent preparedness for future pandemics. We also provide a descriptive outline for paper-based diagnostic platforms, involving the determination mechanisms, as well as a commercial kit for COVID-19 as well as their outlook.